Technical Analysis for ORMP - Oramed Pharmaceuticals Inc.

Grade Last Price % Change Price Change
C 8.91 -0.45% -0.04
ORMP closed down 0.45 percent on Friday, February 26, 2021, on 51 percent of normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Down
Historical ORMP trend table...

Date Alert Name Type % Chg
Wide Bands Range Expansion 0.00%
New Downtrend Bearish -0.45%
Outside Day Range Expansion -0.45%
Wide Bands Range Expansion -0.45%
Wide Bands Range Expansion -4.91%
1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Spinning Top Other 0.00%
Wide Bands Range Expansion 0.00%
Fell Below 20 DMA Bearish -5.01%
Older End-of-Day Signals for ORMP ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 5% 3 days ago
Fell Below Previous Day's Low 3 days ago
Down 3% 3 days ago
Down 2 % 3 days ago
Down 1% 3 days ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Oramed Pharmaceuticals Inc. Description

Oramed Pharmaceuticals, Inc., a pharmaceutical company, engages in the research and development of pharmaceutical solutions for the use of orally ingestible capsules or pills for delivery of polypeptides. The company's products primarily comprise ORMD0801, an oral insulin capsule that is in Phase II clinical trials for the treatment of diabetes; and ORMD0901, an analog for GLP-1 gastrointestinal hormone that is in per-clinical trials. Its portfolio of product candidates is based on intellectual property that allows for the protection of proteins and polypeptides in the stomach, and for their absorption through the gastrointestinal wall. The company was formerly known as Integrated Security Technologies, Inc. and changed its name to Oramed Pharmaceuticals Inc. in April 2006. Oramed Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in Jerusalem, Israel.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Pharmaceutical Pharmaceutical Industry Diabetes Medication Gastrointestinal Dosage Forms Endocrine System Insulin Polyp Peptides Salem Peptide Hormones Treatment Of Diabetes Rusal Glucagon Like Peptide 1 Integrated Security Tablet Pharmaceutical Solutions

Is ORMP a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 11.7
52 Week Low 2.4
Average Volume 663,728
200-Day Moving Average 4.20
50-Day Moving Average 6.78
20-Day Moving Average 9.83
10-Day Moving Average 10.01
Average True Range 0.90
ADX 48.96
+DI 21.48
-DI 22.25
Chandelier Exit (Long, 3 ATRs ) 9.00
Chandelier Exit (Short, 3 ATRs ) 9.09
Upper Bollinger Band 11.76
Lower Bollinger Band 7.89
Percent B (%b) 0.26
BandWidth 39.37
MACD Line 0.74
MACD Signal Line 1.12
MACD Histogram -0.3801
Fundamentals Value
Market Cap 210.95 Million
Num Shares 23.7 Million
EPS -0.87
Price-to-Earnings (P/E) Ratio -10.19
Price-to-Sales 29.55
Price-to-Book 2.81
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 10.31
Resistance 3 (R3) 10.32 9.88 10.07
Resistance 2 (R2) 9.88 9.52 9.87 9.99
Resistance 1 (R1) 9.39 9.30 9.17 9.38 9.92
Pivot Point 8.95 8.95 8.84 8.94 8.95
Support 1 (S1) 8.46 8.59 8.24 8.45 7.90
Support 2 (S2) 8.02 8.37 8.01 7.83
Support 3 (S3) 7.53 8.02 7.75
Support 4 (S4) 7.52